Literature DB >> 12789192

Cutis marmorata telangiectatica congenita with hemangiomatous histopathologic features.

Mayumi Fujita1, Gary L Darmstadt, James G Dinulos.   

Abstract

Cutis marmorata telangiectatica congenita (CMTC) is a congenital cutaneous vascular malformation that is diagnosed on the typical clinical findings of persistent cutis marmorata, telangiectasia, phlebectasia, occasional ulceration and atrophy, and tendency for clinical improvement. Histopathologic findings seldom have been reported. We report a case of CMTC with atypical histopathologic findings of proliferation of vasculature in addition to dilated capillaries in the dermis. We have reviewed all cases of CMTC with histopathologic findings published in the English-language literature. The most common and prominent finding was dilation of capillaries and veins in the dermis (13/15 cases). Two cases, including our own, demonstrated proliferation of vascular channels. The implications of vascular proliferation on the clinical course of CMTC are unclear.

Entities:  

Mesh:

Year:  2003        PMID: 12789192     DOI: 10.1067/mjd.2003.301

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  Cutis marmorata telangiectatica congenita with gangrenous ulceration and hypovolaemic shock.

Authors:  I-Jan Hu; Ming-Ting Chen; Hao-Chih Tai; Po-Nien Tsao; Hung-Chieh Chou; Wu-Shiun Hsieh
Journal:  Eur J Pediatr       Date:  2005-04-06       Impact factor: 3.183

2.  Cutis marmorata telangiectatica congenita restricted to both breasts in a young female.

Authors:  Snehal Balvant Lunge; Pradeep Mahajan
Journal:  Dermatol Pract Concept       Date:  2014-07-31

3.  Cutis marmorata telangiectatica congenita with skin ulcerations in a new born.

Authors:  Rita Chatterjee; Subhendu Dey
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

4.  Cutis marmorata telangiectatica congenita in a preterm newborn - Case report and literature review.

Authors:  A Matic; S Pricic; Milan Matic; G Velisavljev Filipovic; A Ristivojevic
Journal:  Iran Red Crescent Med J       Date:  2012-09-30       Impact factor: 0.611

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.